Date: 2016-11-29
Type of information: Collaboration agreement
Compound: services for the development, production and testing of bio/pharmaceutical products
Company: Accinov (France) Biodextris (Canada)
Therapeutic area: Technology - Services
Type agreement: collaboration co-marketing
Action mechanism:
Disease:
Details: * On November 29, 2016, Accinov and Biodextris announced the signing of a co-marketing agreement, presenting customers with an alternative to traditional contract development and manufacturing organizations (CDMO) for the development, production and testing of bio/pharmaceutical products.
Under the terms of the non-exclusive co-operative agreement, the two companies will work together to co-promote their complementary services to clients in Europe, North America and beyond. Accinov will be able to present clients to Biodextris’ process development, analytical development and cGMP QC testing services, while Biodextris can introduce clients to Accinov’s flexible, ready-touse cGMP biomanufacturing environment and associated quality assurance services. Clients will benefit from a seamless customer experience thanks to the coordinated approach, aligned expertise and shared focus on delivering integrated solutions for clients developing
innovative biologic products.
Financial terms:
Latest news:
